The US president has announced a new deal that would lower the price of some weight loss medications A representative of pharmaceutical industry collapsed in the

President Donald Trump on Thursday unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity

Running may help burn calories, but when it comes to preventing diabetes and obesity, pumping iron might have the edge, according to preclinical findings. The

Jeffrey A. Singer On November 6, President Donald Trump announced that the government will refrain from tariffs on Eli Lilly’s and Novo Nordisk’s imported products

Markets Are we late in the technology megatrend? (awealthofcommonsense.com) A look at how 2025’s stock market stacks up. (carsongroup.com) Apple Apple ($AAPL) has teamed with

President Trump’s plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular GLP-1 weight loss drugs.

President Trump’s plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular GLP-1 weight loss drugs.

On this week’s episode of “The Readout LOUD”: “Mean Girls” melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk bidding

What You Should Know:  – President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements

WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular

President Donald Trump announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 weight loss drugs Wegovy and

Trump says Medicare can now cover weight loss drugs like Ozempic  Axios Certain obesity drugs will cost as little as $149 and Medicare will start covering

Live updates: Democrats weigh shutdown deal; FAA cuts air traffic; Donald Trump announces GLP-1 deal  The Hill

A White House guest collapsed in the Oval Office on Thursday during President Trump’s announcement on lowering drug prices. President Trump unveiled new agreements with

HHS Secretary Robert F. Kennedy Jr.’s plans to rewrite the rules concerning pharmaceutical advertising is hardly novel. Every few years Washington revives this perennial idea—typically proffered to “save” money or

Trump strikes deal to lower cost of weight loss drugs. For more context and news coverage of the most important stories of our day, click

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare recipients and those who pay

Eli Lilly’s oral obesity pill orforglipron was among the next six drugs to win the FDA’s National Priority Voucher, offering the GLP-1 drug candidate a

President Donald Trump announced on Thursday that he’s reached deals with major pharmaceutical companies to lower the costs of popular weight loss drugs known as

The Trump administration announced price cuts for GLP-1 weight-loss drugs Zepbound and Wegovy, with direct-to-consumer access via TrumpRX in 2026. READ: https://www.usatoday.com/story/news/politics/2025/11/06/trump-medicare-coverage-weight-loss-drugs/87122843007/

Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and

The Daily Beast reports: Donald Trump has outed White House communications chief and resident attack dog Steven Cheung as a user of “fat drugs.” Announcing

The Trump administration made a deal with pharmaceutical giants Eli Lilly and Novo Nordisk to lower prices for blockbuster anti-obesity and diabetes medications in the

The deal could expand coverage and lower the price of GLP-1 medications for millions of Americans.

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments

A pharmaceutical rep collapsed in the Oval Office on Thursday right as Eli Lilly‘s David Ricks was discussing a weight loss drug deal during a press conference

President Trump unveils deal to expand coverage, lower costs on GLP-1 obesity drugs like Wegovy  News4JAX

(MedPage Today) — Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to maintain their improvements

Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook  Yahoo Finance Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to

Key Points Sluggish growth for Novo Nordisk’s GLP-1 drugs caused the company to again reduce its full-year sales guidance. Novo Nordisk faces challenges from the

President Donald Trump has announced a landmark deal aiming to expand Medicare coverage to include certain weight-loss medications, a move that could dramatically change access

President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. doubled down on their controversial claims about Tylenol during an Oval Office

President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs. ANDREW CABALLERO-REYNOLDS/AFP

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments

Post Content

With Donald Trump reaping his lowest approval rating of all-time, it’s only natural he’d scramble to throw voters a bone. Apparently, that came in the

Health and Human Services Secretary Robert F. Kennedy Jr. is working on identifying and tackling the root causes of America’s obesity epidemic. In the meantime,

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, striking deals with Novo Nordisk and Eli Lilly to sell their

President Donald Trump on Thursday announced deals with pharmaceutical giants Novo Nordisk and Eli Lilly that would cut the cost of the lowest doses of

Trump, long fixated on ‘fat drug,’ to announce deal to lower its price  The Washington Post Trump announces deals with Eli Lilly, Novo Nordisk to slash